Cortechs.ai | RANO 2D and 3D Measurements as a Companion Diagnostic Tool in NeuroQuant Brain Tumor

RANO 2D and 3D Measurements as a Companion Diagnostic Tool in NeuroQuant Brain Tumor

When it comes to brain tumor diagnosis and management, accurate measurement is crucial for guiding treatment decisions and monitoring patient progress. The Response Assessment in Neuro-Oncology (RANO) criteria, which rely on both 2D and 3D measurements, have become the standard for evaluating brain tumor size and response to treatment.

The Importance of Accurate Tumor Measurement

For patients with brain tumors, small differences in measurements can have a significant impact on treatment outcomes. Traditional 2D measurements, while effective, have limitations when it comes to capturing the full scope of tumor growth or reduction. This is where 3D measurements come in, offering a more comprehensive view of tumor size and shape.

How NeuroQuant Streamlines RANO Measurements

NeuroQuant’s Brain Tumor module simplifies the RANO measurement process by automatically segmenting and quantifying tumors in both 2D and 3D. By providing clinicians with consistent, accurate data, NeuroQuant reduces the time spent manually analyzing scans and enhances diagnostic precision. With the ability to model tumors in three dimensions, clinicians can better assess tumor volume and progression, improving treatment planning.

In conclusion, NeuroQuant’s integration of RANO 2D and 3D measurements provides a powerful companion diagnostic tool for clinicians. By automating this process, NeuroQuant ensures that healthcare providers can make more informed decisions, ultimately improving patient outcomes.

More Resources

06/11/2025

Cortechs.ai and RMS Medical Devices Forge Distribution Partnership to Expand Access to AI-Powered Imaging Solutions in the Benelux Region

We’re excited to announce our new partnership with RMS Medical Devices to our advanced neuroimaging and prostate imaging solutions to the Benelux region

06/04/2025

Cortechs.ai and deepc Announce Strategic Partnership to Advance AI Integration in Radiology

Press Release: Delivering Clinically Validated AI Solutions for Enhanced Imaging Precision and Workflow Efficiency

05/29/2025

Enhancing Imaging Workflow with DICOM SR: NeuroQuant®’s Seamless Integration 

As imaging becomes more data-driven, tools like NeuroQuant® with DICOM SR support pave the way for smarter, more connected radiology

05/18/2025

Cortechs.ai and ALZ-NET Announce Strategic Collaboration to Improve Alzheimer’s Disease Care Through AI-Driven Imaging

This new strategic collaboration aims to enhance the quality of care for people living with Alzheimer’s disease.

05/16/2025

Case Study: NeuroQuant® for ARIA: Monitoring ARIA Progression in Early Alzheimer’s Disease

Dr. Suzie Bash highlights how advanced imaging with NeuroQuant for ARIA supported detection and monitoring of ARIA-E and ARIA-H in an 81-year-old patient.

05/13/2025

Dr. Ana M. Franceschi Joins Cortechs.ai Medical Advisory Board

Neuroimaging thought leader to enhance PET/MRI and dementia research impact through AI-powered tools